Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity
Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France
Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the acquisition of DIABNEXT, a Paris-based company whose digital health platform helps people with diabetes better manage their conditions and connects to their healthcare providers, so they can
Read More
Biotech
Crisis in the U.S. Healthcare Workforce: Why It’s Time to introduce AI
One of the many acute challenges during the pandemic has been the departure of approximately 18% of the U.S. healthcare workforce,4 resulting in staffing shortages in hospitals. This has impacted the well-being of the remaining healthcare practitioners 5 as well as their patients – many of whom are deferring care that is vital to disease management and overall maintenance of health,6,7 or who do not have access to timely emergency care.1 Though such challenges may be perceived as insurmountable
Read More
Definitive Healthcare Acquires Analytical Wizards, Healthcare Analytics Platform
What You Should Know:
- This week, Definite Healthcare announced the acquisition of Analytical Wizards, an advanced analytics company revolutionizing analytics in healthcare by combining our AI/ML-powered technology, domain expertise, and high-touch relationship model. Financial details of the acquisition were not disclosed.
- Founded in 2015, Analytical Wizards automates complex analytic models using tools that expedite efficient big data mining using artificial intelligence (AI) and
Read More
C2i Genomics, Twist Bioscience Partner to Develop Whole-Genome Cancer Reference Materials
What You Should Know:
- Today, Twist Bioscience and cancer genomics startup C2i Genomics announced a partnership to develop whole-genome cancer reference materials.
- This resource will provide diagnostic labs around the globe with the ability to better validate and monitor the quality of their whole-genome cancer screening and minimal residual disease (MRD) products for more accurate cancer detection.
C2i to integrate Twist’s library preparation kits into minimal residual
Read More
7 Burning Questions from Life Sciences Companies on Using AI Agents
Each day life science companies respond to numerous medical information inquires – many of which are similar in nature or can be simply addressed. However, as we have seen in the news reports with the Great Resignation and many workers searching for new careers, the number of individuals interested in working in a medical information contact center may be waning. When you combine this with the rising volume of inquiries or medical inquiries and patient expectations for a real-time response to
Read More
Biotech R&D Platform Benchling Closes $100M at $6B Valuation
What You Should Know:
Biotech R&D platform Benchling raises $100M at a $6B valuation, co-led by Franklin Templeton and Altimeter Capital to expand product development and global footprint, particularly in EMEA.
More than 200,000 scientists at over 600 companies and 7,000 research institutions globally have adopted Benchling's R&D Cloud to make breakthrough discoveries and bring the next generation of medicines, food, and materials to market faster than ever before. The R&D
Read More
Biotech Company Nuritas Raises $45M To Scale Its Peptide Discovery Platform
What You Should Know:
- Nuritas, a biotech company that uses proprietary AI to discover plant-based actives (peptides) and make the products we consume healthier and more sustainable raises $45M in Series B funding led by Cleveland Avenue, LLC. The round also included participation from Cultivian Sandbox Ventures, VisVires New Protein, U2’s Bono and The Edge, Salesforce CEO Marc Benioff and Ali Partovi.
- Founded in 2014, Nuritas’ computational approach to discovery uses
Read More
Lightstone Ventures Raises $375M Fund to Invest in Early Stage Biotech and Medtech Companies
What You Should Know:
- Lightstone Ventures today announced the closing of Lightstone Ventures III with $375M in capital commitments, to invest in early-stage companies developing high-impact therapeutics and technologies.
- The new fund was oversubscribed, exceeding the firm’s targeted raise, and included strong support from both new and existing limited partners. With the closing Fund III, Lightstone Ventures also announced the appointments of Christina Isacson, Ph.D., as Partner and
Read More
Fresenius Medical Invests Additional $25M in Biotech Platform Humacyte
What You Should Know:
Fresenius Medical Care (FMC) today announced its plans to invest an additional $25 million in clinical-stage biotechnology platform company Humacyte following the extension of its collaboration in June. Fresenius Medical Care acquired a stake in Humacyte in 2018 for $150M as part of a strategic partnership.
Following the merger of Humacyte with a special purpose acquisition company (SPAC), FMC is increasing its position in the newly combined
Read More
5-Step Guide to Hiring AI Talent for Digital Health, Biotech & Life Sciences Companies
Artificial Intelligence (AI) will disrupt healthcare's destiny for good. Here are five steps digital health startups can take to find the premier talent to get the job done.
Not too long ago, AI was the topic of futuristic movies. What was once a fictional draw at the Box Office is now a reality in offices worldwide. AI is everywhere and rapidly transforming the way we work. What remains scarce though is the technical talent in healthcare to see this tech revolution through.
AI
Read More
